Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 148
Genomics 73
Biopharmaceuticals 72
Immune Disorders Drugs 70
Biotechnology 50
Musculoskeletal Disorders Drugs 42
Pharmaceuticals 41
Oncology Drugs 40
Drug Discovery 38
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 26
Infusions and Injectables 24
Cardiovascular Drugs 23
Allergy and Immunology 22
Optical Disorders Drugs 21
Clinical Trials 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 16
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Optical 13
Infectious Diseases Drugs 12
Gastrointestinal Drugs 12
Immunosuppressive Drugs 12
Healthcare Services 11
Analgesics 11
Hematology 11
Drug Delivery 10
Pharmaceutical Manufacturing 10
Lymphoma Drugs 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Drugs by Therapeutic Area 8
Leukemia Drugs 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Medical Devices 6
Enzymes 5
Neurology Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Gastroenterology 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Surgical Devices 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Palliative Care 1
Pediatrics 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



283 reviews

847 Results (Page 34 of 43)
- Relevance
  Sort by

Inflammatory Bowel Disease Treatment Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3757EUR$4,150USD£3,218GBP

Checkpoint Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4064EUR$4,490USD£3,482GBP

Antibody Drug Conjugates Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4064EUR$4,490USD£3,482GBP

TNF Alpha Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4064EUR$4,490USD£3,482GBP

Polymer Drug Conjugate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
94 Pages
Global

From

€3500EUR$4,142USD£3,103GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Multiple System Atrophy (MSA) - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
January 2025
194 Pages
Global

From

€7196EUR$7,950USD£6,165GBP

RNA Interference- Pipeline Insight, 2025

 Drug Pipelines
April 2025
204 Pages
Global

From

€2716EUR$3,000USD£2,326GBP

Tumor Necrosis Factor Inhibitor Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4064EUR$4,490USD£3,482GBP

Chemotherapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4064EUR$4,490USD£3,482GBP

Systemic Lupus Erythematosus - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
May 2026
115 Pages
Global

From

€4300EUR$4,750USD£3,684GBP

Leukemia Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
95 Pages
Global

From

€3500EUR$4,142USD£3,103GBP

Immunomodulator Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
102 Pages
Global

From

€3500EUR$4,142USD£3,103GBP

Alzheimer's Disease: Global Drug Forecast and Market Analysis to 2028

 Report
May 2020
218 Pages
Global

From

€13574EUR$14,995USD£11,628GBP

Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
Global

From

€4073EUR$4,500USD£3,490GBP

Dementia Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Drug Pipelines
July 2024
100 Pages
Global

From

€3395EUR$3,750USD£2,908GBP

Biobetter Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
112 Pages
Global

From

€3500EUR$4,142USD£3,103GBP

Human Coagulation Factor VII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
93 Pages
Global

From

€3500EUR$4,142USD£3,103GBP

Human Coagulation Factor VIII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
111 Pages
Global

From

€3500EUR$4,142USD£3,103GBP

Human Coagulation Factor IV Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
104 Pages
Global

From

€3500EUR$4,142USD£3,103GBP

Hemophilia B Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
114 Pages
Global

From

€3500EUR$4,142USD£3,103GBP

847 Results (Page 34 of 43)
- 1
- 32
- 33
- 34
- 35
- 36

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.